← Back to home

Inert B-cell lymphoma transformed into large B-cell lymphoma (excluding richter transformation, THRLBCL, and BL)

Clinical trials for Inert B-cell lymphoma transformed into large B-cell lymphoma (excluding richter transformation, THRLBCL, and BL) explained in plain language.

Never miss a new study

Get alerted when new Inert B-cell lymphoma transformed into large B-cell lymphoma (excluding richter transformation, THRLBCL, and BL) trials appear

Sign up with your email to follow new studies for Inert B-cell lymphoma transformed into large B-cell lymphoma (excluding richter transformation, THRLBCL, and BL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New CAR-T therapy takes aim at tough lymphoma cancers

Disease control Not yet recruiting

This early-phase study tests a new treatment called CY-219 CAR-T cells in 18 people whose B-cell lymphoma has come back or stopped responding to standard care. The therapy uses a patient's own immune cells, modified to better recognize and attack cancer cells. The main goals are …

Matched conditions: INERT B-CELL LYMPHOMA TRANSFORMED INTO LARGE B-CELL LYMPHOMA (EXCLUDING RICHTER TRANSFORMATION, THRLBCL, AND BL)

Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Jun 27, 2026 12:10 UTC

Inert B-cell lymphoma transformed into large B-cell lymphoma (excluding richter transformation, THRLBCL, and BL)

Get alerted when new Inert B-cell lymphoma transformed into large B-cell lymphoma (excluding richter transformation, THRLBCL, and BL) trials appear

New CAR-T therapy takes aim at tough lymphoma cancers